Literature DB >> 22210330

Empirical versus pre-emptive antifungal therapy for persistent febrile neutropenia.

Elio Castagnola, Riccardo Haupt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22210330      PMCID： PMC3248937          DOI： 10.3324/haematol.2011.056077

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

1.  The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.

Authors:  Livio Pagano; Morena Caira; Annamaria Nosari; Chiara Cattaneo; Rosa Fanci; Alessandro Bonini; Nicola Vianelli; Maria Grazia Garzia; Mario Mancinelli; Maria Elena Tosti; Mario Tumbarello; Pierluigi Viale; Franco Aversa; Giuseppe Rossi
Journal:  Haematologica       Date:  2011-05-12       Impact factor: 9.941

2.  Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

Authors:  Catherine Cordonnier; Cécile Pautas; Sébastien Maury; Anne Vekhoff; Hassan Farhat; Felipe Suarez; Nathalie Dhédin; Francoise Isnard; Lionel Ades; Frédérique Kuhnowski; Françoise Foulet; Mathieu Kuentz; Patrick Maison; Stéphane Bretagne; Michaël Schwarzinger
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079
  2 in total
  2 in total

1.  Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.

Authors:  Marisa Z R Gomes; Victor E Mulanovich; Y Jiang; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

Review 2.  Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1).

Authors:  Hamdi Akan; Seniz Ongören Aydın; Neşe Saltoğlu; Atahan Cağatay; Halis Akalın; Mutlu Arat; Rıdvan Ali; Sevgi Kalayoğlu-Beşışık; A Muzaffer Demir
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.